- Home
- REVB vs CNET Comparison
REVB vs CNET Comparison
Compare REVB & CNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- CNET
- Stock Information
- Founded
- REVB 2020
- CNET 2003
- Country
- REVB United States
- CNET Hong Kong
- Employees
- REVB N/A
- CNET N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- CNET Advertising
- Sector
- REVB Health Care
- CNET Consumer Discretionary
- Exchange
- REVB Nasdaq
- CNET Nasdaq
- Market Cap
- REVB 3.7M
- CNET 3.3M
- IPO Year
- REVB N/A
- CNET N/A
- Fundamental
- Price
- REVB $0.75
- CNET $1.51
- Analyst Decision
- REVB
- CNET
- Analyst Count
- REVB 0
- CNET 0
- Target Price
- REVB N/A
- CNET N/A
- AVG Volume (30 Days)
- REVB 2.9M
- CNET 705.0K
- Earning Date
- REVB 08-08-2025
- CNET 08-15-2025
- Dividend Yield
- REVB N/A
- CNET N/A
- EPS Growth
- REVB N/A
- CNET N/A
- EPS
- REVB N/A
- CNET N/A
- Revenue
- REVB N/A
- CNET $13,560,000.00
- Revenue This Year
- REVB N/A
- CNET N/A
- Revenue Next Year
- REVB N/A
- CNET N/A
- P/E Ratio
- REVB N/A
- CNET N/A
- Revenue Growth
- REVB N/A
- CNET N/A
- 52 Week Low
- REVB $0.71
- CNET $1.11
- 52 Week High
- REVB $56.00
- CNET $4.53
- Technical
- Relative Strength Index (RSI)
- REVB 24.83
- CNET 56.25
- Support Level
- REVB $0.74
- CNET $1.14
- Resistance Level
- REVB $0.98
- CNET $1.43
- Average True Range (ATR)
- REVB 0.06
- CNET 0.18
- MACD
- REVB 0.07
- CNET 0.02
- Stochastic Oscillator
- REVB 14.81
- CNET 56.92
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.